PAPER Liu Y, Prasad R, Wilson SH
SEARCH RESULTS
329930 RESULTS
PAPER Grosset D
Parkinson's disease and related disorders--XVIII WFN World Congress.
IDrugs. 2010 Feb;13(2):82-4. PubMed: 20127558PAPER Sen AP, Gulati A
Use of magnesium in traumatic brain injury.
Neurotherapeutics. 2010 Jan;7(1):91-9. PubMed: 20129501PAPER Gupte AA, Morris JK, Zhang H, Bomhoff GL, Geiger PC, Stanford JA
Age-related changes in HSP25 expression in basal ganglia and cortex of F344/BN rats.
Neurosci Lett. 2010 Mar 19;472(2):90-3. PubMed: 20144690PAPER Weisskopf MG, Knekt P, O'Reilly EJ, Lyytinen J, Reunanen A, Laden F, Altshul L, Ascherio A
Persistent organochlorine pesticides in serum and risk of Parkinson disease.
Neurology. 2010 Mar 30;74(13):1055-61. PubMed: 20350979PAPER Heikal AA
Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies.
Biomark Med. 2010 Apr;4(2):241-63. PubMed: 20406068PAPER Ticozzi N, Ratti A, Silani V
Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage.
CNS Neurol Disord Drug Targets. 2010 Jul;9(3):285-96. PubMed: 20406182PAPER Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM
Glucocorticoids, cytokines and brain abnormalities in depression.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):722-9. PubMed: 20406665Robert Cherny
The Mental Health Research InstituteParkville, Australia
PAPER Chertkow H, Nikelski J, Leger G, Litwin L, Whitehead V, Evans A
Using FDG PET and PIB (Pittsburgh B) PET imaging to distinguish atypical Alzheimer’s disease and fronto-temporal dementia cases.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Chau WF, Peterson S, Farrar G, Eko-Ebongue S, Barnes C
Evaluation of metabolites of [18F]flutemetamol, an amyloid imaging agent in human and rat in vitro and rat in vivo models.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Carpenter AP, Pontecorvo MJ, Sadowsky C, Hassman HA, Edell S, Clark CM, Hefti F, Joshi A, Burns J, Skovronsky DM
Pharmacokinetics and pharmacodynamics of 18F-AV-45 (florbetapir F 18) PET imaging in Alzheimer’s disease (AD) and healthy control subjects: results of a phase II trial: 18F-AV-45-A03.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Carmasin JS, Maye JE, Marshall GA, Becker JA, Sperling RA, Rentz DM, Johnson KA
Overestimation of memory performance in normal elderly subjects is associated with amyloid burden in the temporal lobeOverestimation of memory performance in normal elderly subjects is associated with amyloid burden in the temporal lobe.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Brück A, Locascio JJ, Gomperts SN, Rentz DM, Becker JA, Memole L, Carmasin J, Maye J, Growdon J, Johnson KA
Patterns of amyloid deposition distinguish non-demented Parkinson’s disease from normal aging.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Morris JC, Roe CM, Grant EA, Holtzman DM, Fagan AM, Mintun MA
PIB Imaging and CSF biomarkers predict cognitive impairment and dementia of the Alzheimer type (DAT).
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;Current Filters
No filters selected